On the other hand, this transcription factor has been found to regulate the expression of obesity-related bioactive molecules (i.e., IL-6, IGF-1, and leptin) [137,138,139], further suggesting the potential role of CEBP-β in mediating BC cell/adipocyte crosstalk. This evidence concerns the gene IGF1 and obesity disorder.